In the original publication [1], a wording error was introduced. Throughout the manuscript, Risk Ratio (RR) is used for comparisons. However, in the manuscript text, in Tables 3 and 4 and in the legends for Tables 3 and 4, the term Odds Ratio (OR) was mistakenly used instead of the correct Risk Ratio (RR). This error is limited to the terminology; the numerical values presented remain correct and correspond to RR. The only instance where Odds Ratio (OR) was actually used is in the random effects model, which is described in the manuscript but not included in the tables. In this context, Odds Ratio (OR) is the appropriate effect measure, and it is correctly reported. The results and conclusions of this study remain unaffected by this mistake.
The terminology has now been corrected in Table 3 and Table 4 and their legends, as shown below and in the manuscript. This correction was approved by the Academic Editor. The original publication has been updated.
Table 3.
Primary outcome in the study population, which are presented as Risk ratios (RR) and 95% confidence intervals (CI). Data are presented in all patients and in the subgroup of patients with shockable (ventricular fibrillation or pulseless ventricular tachycardia) and non-shockable (asystole and pulseless electric activity) initial rhythm. CPC = Cerebral Performance Category.
Table 3.
Primary outcome in the study population, which are presented as Risk ratios (RR) and 95% confidence intervals (CI). Data are presented in all patients and in the subgroup of patients with shockable (ventricular fibrillation or pulseless ventricular tachycardia) and non-shockable (asystole and pulseless electric activity) initial rhythm. CPC = Cerebral Performance Category.
| Primary Outcome | Intervention | Control | Difference (95% CI) | Risk Ratio (95% CI) | p-Value |
|---|---|---|---|---|---|
| Survival with CPC 1–2 at 90 days, n (%) | |||||
| All patients | 56/149 (37.6%) | 45/142 (31.7%) | 5.9 [−5.2–16.8] | 1.19 [0.86–1.63] | 0.29 |
| Shockable rhythm | 48/83 (57.8%) | 35/78 (44.9%) | 12.9 [−2.4–28.3] | 1.29 [0.95–1.75] | 0.10 |
| Non-shockable rhythm | 8/66 (12.1%) | 10/64 (15.6%) | −3.3 [−15.3–8.6] | 0.79 [0.33–1.87] | 0.58 |
Table 4.
Secondary outcomes in the population, which are presented as Risk ratios (RR) and 95% confidence intervals (CI). Data are presented in all patients and in the subgroup of patients with shockable (ventricular fibrillation or pulseless ventricular tachycardia) and non-shockable (asystole and pulseless electric activity) initial rhythm. CPC = Cerebral Performance Category.
Table 4.
Secondary outcomes in the population, which are presented as Risk ratios (RR) and 95% confidence intervals (CI). Data are presented in all patients and in the subgroup of patients with shockable (ventricular fibrillation or pulseless ventricular tachycardia) and non-shockable (asystole and pulseless electric activity) initial rhythm. CPC = Cerebral Performance Category.
| Secondary Outcome | Intervention | Control | Difference (95% CI) | Risk Ratio (95% CI) | p-Value |
|---|---|---|---|---|---|
| Overall survival at 90 days, no (%) | |||||
| All patients | 60/149 (40.3%) | 52/142 (36.6%) | 3.7 [−7.5–14.8] | 1.10 [0.82–1.47] | 0.09 |
| Shockable rhythm | 51/83 (61.4%) | 41/78 (52.6%) | 8.8 [−6.4–24.1] | 1.17 [0.89–1.53] | 0.25 |
| Non-shockable rhythm | 9/66 (13.6%) | 11/64 (17.1%) | −3.5 [−15.8–9.1] | 0.81 [0.36–1.81] | 0.36 |
| Survival with CPC 1 at 90 days, no (%) | |||||
| All patients | 50/149 (33.6%) | 35/142 (24.6%) | 9.0 [−1.5–19.3] | 1.36 [0.94–1.96] | 0.11 |
| Shockable rhythm | 45/83 (54.2%) | 27/78 (34.6%) | 19.6 [4.6–34.6] | 1.57 [1.09–2.25] | 0.01 |
| Non-shockable rhythm | 5/66 (7.6%) | 8/64 (12.5%) | −5.0 [−15.2–5.6] | 0.62 [0.21–1.78] | 0.60 |
Reference
- MACCHINI, E.; DILLENBECK, E.; JONSSON, M.; ANNONI, F.; FORSBERG, S.; HOLLENBERG, J.; TRUHLAR, A.; SVENSSON, L.; NORDBERG, P.; TACCONE, F.S. Intra-Arrest Therapeutic Hypothermia and Neurologic Outcome in Patients Admitted after Out-of-Hospital Cardiac Arrest: A Post Hoc Analysis of the Princess Trial. Brain Sci. 2022, 12, 1374. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).